Tag Archives: Medicines

eC2: Multi-stakeholder platform for knowledge sharing on access solutions for innovative medicines

Posted on by

Deadline: 31-Aug-2017 at 11:59:59 PM (Eastern Time – Washington D.C.)

 

The initial scope and purpose of the multi-stakeholder platform for knowledge sharing medical-appointment-doctor-healthcare-clinic-health-hospital-medicine[7]on access solutions for innovative medicines (henceforth, the Platform) will be to develop and share knowledge and tools for smarter decision making on access strategies for patented medicines for NCDs, through a collaborative approach. The Platform will leverage the pharmaceutical industry’s capacity for developing innovative access solutions and the World Banks role as a strategic long term partner for developing countries and its convening power, to create a reference policy and implementation framework and decision-making tools for maximizing reach of new treatments for populations that typically would not have access to patented medicines, ultimately driving uptake of voluntary access strategies in developing countries.

Continue reading →

eC2: Exploring options for a back-up supply system for essential medicines in Sierra Leone

Posted on by

Deadline: 21-Aug-2017 at 11:59:59 PM (Eastern Time – Washington D.C.) medical-appointment-doctor-healthcare-clinic-health-hospital-medicine[7]

It is for the development of a tentative business plan for a back-up medicines supply system for public health facilities in the Kailahun and Koinadugu districts.
The consultant is expected to conduct interviews with stakeholders (including those in the two districts) and review existing documentation from various sources, with the goal of: 1, dentifying the list of medicines that is offered through the back-up system
2, Identifying the manufacturers of these medicines that are already licensed in Sierra Leone and verifying the quality standards
3, Identifying potential service providers for the back up system
4, Quantifying the potential demand based on the best possible assumptions of consumption/need and availability in the public supply chain
5, Comparing pros and cons of different pricing/compensation models for a contract with private importers
6, Addressing issues of financing for buffer stock
7, Finding solutions to ensure timely payment.

Based on the findings, a business plan is expected.
Continue reading →